Skip to content

Clinical trials

Completed Carcinoma, Non-Small-Cell Lung trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Completed Country / region: Singapore Clear all

87 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20043
20051
20067
20074
20088
20093
20103
20115
20125
20138
20147
20159
20164
20173
20181
20197
20205
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed87

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals14
Hoffmann-La Roche8
AstraZeneca7
Boehringer Ingelheim5
National Cancer Centre, Singapore5
Bristol-Myers Squibb4
Bayer3
Eisai Inc.3
National University Hospital, Singapore3
Pfizer3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung87
Lung Neoplasms23
Adenocarcinoma of Lung8
Neoplasms7
Adenocarcinoma4
Breast Neoplasms4
Carcinoma4
Carcinoma, Hepatocellular4
Neoplasm Metastasis4
Carcinoma, Renal Cell3

Trials

Showing 1 to 25 of 87. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.